Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement

NCT05391607 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Blood Loss, Surgical
Fluid Retention

Interventions

DRUG: Hyperoncotic Albumin 20%
DRUG: Isooncotic Albumin 5%
DRUG: Ringer's Lactate Crystalloid Solutions (control group)

Sponsor

Insel Gruppe AG, University Hospital Bern